Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

Clinical trial NCT06829238 · RECRUITING

Trial details

NCT number: NCT06829238
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Inflammation Immune Dysregulation Injection Drug Use HIV

Start date: 2025-04-07
Primary completion: 2028-11-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.